Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 171

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy

Open access
Bailur, Jithendra Kini, McCachren, Samuel S., Doxie, Deon B., Shrestha, Mahesh, Pendleton, Katherine, Nooka, Ajay K., Neparidze, Natalia, Parker, Terri L., Bar, Noffar, Kaufman, Jonathan L., Hofmeister, Craig C., Boise, Lawrence H., Lonial, Sagar, Kemp, Melissa L., Dhodapkar, Kavita M., Dhodapkar, Madhav V. · 2019 · JCI Insight

Abstract

Preneoplastic lesions carry many of the antigenic targets found in cancer cells but often exhibit prolonged dormancy. Understanding how the host response to premalignancy is maintained and altered during malignant transformation is needed to prevent cancer. In order to understand the immune microenvironment in precursor monoclonal gammopathy of undetermined significance (MGUS) and myeloma, we analyzed bone marrow immune cells from 12 healthy donors and 26 MGUS/myeloma patients by mass cytometry and concurrently profiled transcriptomes of 42,606 single immune cells from these bone marrows. Compared to age-matched healthy donors, memory T cells from both MGUS and myeloma patients exhibit greater terminal-effector differentiation. However, memory T cells in MGUS show greater enrichment of stem-like TCF1/7hi cells. Clusters of T cells with stem-like and tissue-residence genes were also found to be enriched in MGUS by single-cell transcriptome analysis. Early changes in both NK and myeloid cells were also observed in MGUS. Enrichment of stem-like T cells correlated with a distinct genomic profile of myeloid cells and levels of Dickkopf-1 in bone-marrow plasma. These data describe the landscape of changes in both innate and adaptive immunity in premalignancy and suggest that attrition of the bone-marrow-resident T cell compartment due to loss of stem-like cells may underlie loss of immune surveillance in myeloma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci.insight.127807

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 171

Metadata

Authors
Bailur, J. K., McCachren, S. S., Doxie, D. B., Shrestha, M., Pendleton, K., Nooka, A. K., Neparidze, N., Parker, T. L., Bar, N., Kaufman, J. L., Hofmeister, C. C., Boise, L. H., Lonial, S., Kemp, M. L., Dhodapkar, K. M., & Dhodapkar, M. V.
Venue
JCI Insight
Published
2019-06-06
Volume
4
Issue
11
ISSN
2379-3708 (ISSN-L)
OpenAlex
W2942334439
Cited by
171
References
8
FWCI
12.09
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy. https://app.cochat.ai/papers/10.1172/jci.insight.127807
The paper
Bailur, J. K., McCachren, S. S., Doxie, D. B., Shrestha, M., Pendleton, K., Nooka, A. K., Neparidze, N., Parker, T. L., Bar, N., Kaufman, J. L., Hofmeister, C. C., Boise, L. H., Lonial, S., Kemp, M. L., Dhodapkar, K. M., & Dhodapkar, M. V. (2019). Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy. JCI Insight. https://doi.org/10.1172/jci.insight.127807

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.